• Skip to main content
  • Skip to footer

PeDRA

Pediatric Dermatology Research Alliance

  • Pay 2021 Membership Dues
  • Our Membership
  • Login
MENUMENU
  • Contact
  • For Patients & Families
        • Patient Support
        • Patient Education
        • Find a Pediatric Dermatologist (from SPD)
        • Clinical Trials
        • Patient Advisory Committee
        • Learn more about PeDRA’s efforts to build capacity for patient engagement in pediatric dermatology research.

           

  • Education and Events
        • Virtual Education
        • PeDRA Podcasts
        • Mentorship Program
        • Early Career Support
        • 2021 PeDRA Annual Conference
        • Past PeDRA Conferences
        • Upcoming Events
        • Education and Events Archive
        • Save the Date!

          The 2021 PeDRA Annual Conference will take place October 14-16, 2021 in Bethesda, MD.

           

  • Research
        • Grants & Awards
        • Studies
        • Focused Study Groups
        • Publications
        • Clinical Trials
        • Research Fellowships

          Applications are now being accepted to the 2021 PeDRA Research Fellowships program. Deadline to apply is Thursday, April 1, 2021.

  • About
        • Mission & Vision
        • Leadership & Staff
        • Annual Reports
        • News Archive
        • Our Supporters
        • Our Membership
        • Our Committees
        • Getting to Know You
        • PeDRA is an independent 501(c)(3) nonprofit organization driven by the mission to create, inspire, and sustain research to prevent, treat, and cure childhood skin disease.

  • Member Login

Pediatric Dermatology COVID-19 Response Task Force Releases Guidance on Use of Systemic Immunosuppressive Therapy

April 24, 2020 By Mike Siegel

April 22, 2020 – Under the direction of Kelly Cordoro, MD of the University of California, San Francisco the Pediatric Dermatology COVID-19 Response Task Force (PDCRTF) has published a guidance manuscript on the use of systemic immunosuppressive therapies for inflammatory skin diseases in children.  Available on-line in the journal Pediatric Dermatology, the manuscript presents consensus-based recommendations assembled using a survey that completed by 37 experts in the field.    

With this manuscript, the PDCRTF addresses a variety of clinical scenarios, including treatment of patients with no symptoms, upper-respiratory infections without a COVID-19 diagnosis, confirmed COVID-19 exposure, and confirmed COVID-19 diagnoses. It is hoped that the paper can help inform health care providers and families making decisions to initiate or continue use of systemic oral and biologic medications for the treatment of inflammatory skin diseases in children including psoriasis, atopic dermatitis, and alopecia areata.  It also addresses issues facing front-line health care providers like lab monitoring and methods of communicating with patients and families. 

Visit the COVID-19 Information Page for other resources to support pediatric dermatologists, patients, and families during the COVID-19 pandemic.  Explore the PeDRA Publication Page for more on each of PeDRA’s peer-reviewed publications.    

Filed Under: News

Footer

  • Our Membership
  • For Patients
  • For Researchers
  • Forum
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
Sign up to receive emails from PeDRA
Join PeDRA
Donate

Copyright © 2021 · Pediatric Dermatology Research Alliance (PeDRA) · All Rights Reserved. · Privacy Policy